Numinus Wellness Inc. (TSX: NUMI | OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in Wonderland: Miami hosted by Microdose to be held at the Mana Wynwood Convention Center in Miami, FL on November 3-5, 2022.
Dr. Reid Robison, MD MBA, Chief Clinical Officer of Numinus, will participate in the panel Neurobiological Mechanism Difference Between Classic Psychedelics and Ketamine on Saturday, November 5th at 9:50 a.m. ET.
For more information about the conference, or to schedule a one-on-one meeting with Numinus’ management, please send an email to KCSA Strategic Communications NuminusIR@kcsa.com.
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.